002007.SZ Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 apr 2024 @ 09:04):

Stats
Dagens volum	10.06M
Gjennomsnittsvolum	11.62M
Markedsverdi	35.61B
EPS	CNY0.140 ( 2024-04-26 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	25.62
ATR14	CNY0.0150 (0.08%)

Volum Korrelasjon

Lang: -0.07 (neutral)

Kort: 0.00 (neutral)

Signal:(56.306) Neutral

Hualan Biological Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Hualan Biological Korrelasjon - Valuta/Råvare

-0.15
( neutral )

-0.40
( neutral )

0.00
( neutral )

-0.07
( neutral )

-0.56
( weak negative )

0.45
( neutral )

Hualan Biological Økonomi

Annual	2023
Omsetning:	CNY5.30B
Bruttogevinst:	CNY3.56B (67.30 %)
EPS:	CNY0.810

FY	2023
Omsetning:	CNY5.30B
Bruttogevinst:	CNY3.56B (67.30 %)
EPS:	CNY0.810

FY	2022
Omsetning:	CNY4.52B
Bruttogevinst:	CNY2.98B (66.06 %)
EPS:	CNY0.590

FY	2021
Omsetning:	CNY4.44B
Bruttogevinst:	CNY3.05B (68.74 %)
EPS:	CNY0.710

Financial Reports:

No articles found.

Hualan Biological

Hualan Biological Engineering Inc., a biopharmaceutical company, researches, develops, produces, and commercializes plasma products, viral vaccines, bacterial vaccines, and recombinant proteins and other biologics in the People's Republic of China. Its blood products comprise human albumin, human immunoglobulin, intravenous human immunoglobulin, rabies immunoglobulin, hepatitis B human immunoglobulin, tetanus human immunoglobulin, human prothrombin complex, human coagulation factor VIII, lyophilized human thrombin for external use, freeze-dried human fibrin glue for surgery, and human fibrinogen. The company's vaccines consist of influenza virus split vaccine, recombinant hepatitis B vaccine, ACYW135 meningococcal polysaccharide vaccine, A H1N1 influenza virus split vaccine, and quadrivalent influenza virus split vaccine. The company has strategic alliance with the Chinese Academy of Sciences, and other scientific research institutes and scientific research companies. The company was founded in 1992 and is based in Xinxiang, the People's Republic of China.